SaveHealth reports on eczema medications, detailing various options from topical treatments to advanced therapies for managing this chronic skin condition.
Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease mechanisms including IL-13 and therefore makes targeting IL-13 with lebrikizumab a ...
The US Food and Drug Administration (FDA) today announced it has expanded the approval of tralokinumab-ldrm (Adbry) for treating moderate to severe atopic dermatitis (AD) in children 12-17 years old, ...
Eczema is an umbrella term for a group of conditions that result in skin irritation and inflammation. The most common form of eczema, known as atopic dermatitis, is characterized by persistent itching ...
ORLANDO (Nov. 6, 2025) – New research presented at the American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting suggests that the timing of when eczema begins, as well as ...
Verywell Health on MSN
Eczema on dark skin: Common triggers, symptoms, and treatment
Medically reviewed by Casey Gallagher, MD Key Takeaways Eczema on dark skin often looks purplish, brown, or ash-gray, making ...
LEO Pharma A/S, a global leader in medical dermatology, today presented two late-breaking delgocitinib cream presentations for Chronic Hand Eczema (CHE), showcasing the findings for the DELTA TEEN ...
Kim H. from Nevada writes: “I read an article you wrote about how gut health affects the brain and other parts of the body. Our 19-year-old son has severe eczema and is living in Hong Kong. We thought ...
Rising misuse of unregulated creams and delays in treatment are driving more severe eczema cases in Malaysia, specialists ...
Tralokinumab plus optional use of TCS or TCI in adults with moderate to severe AD was associated with stable disease control for up to 4 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback